SOL-Millennium Europesp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-09-28
Share capital
500,000.00 PLN
Registered address
Twarda 18, 00-105 Warszawa, Poland
Electronic delivery address
AE:PL-20405-35222-TUDRT-18

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 54 days early. All were audited by a statutory auditor.

  • 202526/05/2026
  • 202418/04/2025
  • 202321/06/2024
  • 202220/06/2023
  • 202123/06/2022
  • 202021/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 24.78mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 783.66kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 23.22mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 17.94mMedianUSD 609.79kAverageUSD 11.85m

Authorized Representatives

Dariusz Mazurek – Attorney-in-fact (sole)
Fabio Doria – Management Board Member
Lidia Kanach – Attorney-in-fact (sole)

Manner of representation

Each member of the management board is authorised to represent the company independently.

Ownership

OwnerSharesShare valueStake
Sol-millennium Holding Europe Limited
5,000$135,062.13100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2012-09-28.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 12,523

MSiG notices

Publication dateEvent
Jan 20, 2017Return of additional payments
Dec 22, 2016Return of additional payments

Public aid

10 public aid cases recorded, with a total value of $295,822.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$37,997
De minimis aid (in accordance with Commission Regulation 2023/2831)
$24,276
De minimis aid (in accordance with Commission Regulation 2023/2831)
$10,023

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Centrala Farmaceutyczna CefarmS.A.
ITPS.A.
Synkmedsp. z o.o.
Intimexsp. z o.o. + limited partnership
IMC Impomed CentrumS.A.
Gtm-Mobil M-T T.Walisiewiczsp. k.
Reynolds Medicalsp. z o.o.
Petronafsp. z o.o.
CryoprofilS.A.
Novisc Pharmasp. z o.o.

Change history

DateEvent
2025-10-27PKD change
2017-11-23PKD change
2015-09-14PKD change
2014-11-13Address change
2013-04-11Share capital increase

FAQ

Last updated: 2026-10-07